Introduction
Because transplanted myoblasts (skeletal muscle precursor cells) can fuse with endogenous muscle fibers to form hybrid myotubes (Partridge et al., 1989) , myoblast transplantation represents a viable approach for the treatment of inherited myopathies and diseases that are characterized by fiber necrosis and muscle weakness (Gussoni et al., 1997) . Although limitations such as immune rejection or limited spread into host tissue are important, the failure of myoblast transfer in initial clinical trials was partially attributed to poor survival rates of transplanted myoblasts (Gussoni et al., 1997; Mendell et al., 1995; Partridge et al., 1989; Tremblay et al., 1993) . Recent data have suggested that oxidative stress, which is presumably derived from damage resulting from intramuscular implantation, might cause rapid cell death in transplantation experiments. The pre-treatment of muscle precursor cells with antioxidant molecules improves graft survival (Drowley et al., 2010; Rodriguez-Porcel et al., 2010; Suzuki et al., 2004) . Conversely, the inhibition of antioxidant capacity by decreasing glutathione activity impairs the regenerative capacity of muscle-derived stem cells (Drowley et al., 2010) . Although such pro-survival strategies were found to be successful in these studies, the exact mechanisms of action of these molecules have not been determined. Furthermore, it is not clear whether pro-survival strategies can improve the poor adhesion of myoblasts to the cellular matrix under conditions of oxidative stress, which is a phenomenon previously observed upon transplantation of mesenchymal stem cells (MSCs) (Song et al., 2010) . In addition to the difficulties described above, the specific physiopathology status of host dystrophic muscles may cause additional problems.
FacioScapuloHumeral Dystrophy (FSHD) is an autosomal dominant neuromuscular disease characterized by a progressive weakness and atrophy of skeletal muscles (Statland and Tawil, 2011) . In FSHD patients the coexistence of affected muscles and muscles apparently 4 healthy has allowed to propose that myoblasts from unaffected muscles can be purified and implanted in the affected muscles to repair them (Vilquin et al., 2005) . However, FSHD is associated with exacerbated oxidative stress (Barro et al., 2010; Turki et al., 2012; Winokur et al., 2003) that could further limit the efficacy of autologous myoblast transplantation.
Therefore, the enhancement of cell survival should be a principal goal of cell-transplantation techniques.
Aldehyde dehydrogenases (ALDHs) efficiently oxidize and detoxify aldehydic products of lipid peroxidation (LPO) initially generated by reactive oxygen species (Jackson et al., 2011) and contribute to stem cell self-protection, differentiation and/or self-renewal (Balber, 2011; Ma and Allan, 2011) . Recently, we determined that high aldehyde dehydrogenase activity (ALDH high ) is associated with improved cell viability in human myoblasts (Jean et al., 2011) .
In addition, Vauchez et al. (Vauchez et al., 2009 ) and Vella et al. (Vella et al., 2011) have isolated ALDH high muscle progenitors cells that exhibit increased stress resistance and regenerative capacity. Several ALDH enzymes, including Aldh1a1, Aldh1a2 and Aldh1a3 in humans, catalyze the irreversible oxidation of vitamin A (VA) to retinoic acid (RA), which binds and activates nuclear retinoic acid receptor (RAR)/retinoid X receptor (RXR) heterodimers to regulate the transcription of target genes that are important for development, morphogenesis and differentiation (Jackson et al., 2011; Samarut and Rochette-Egly, 2011 ).
Many studies have been conducted to analyze the role of RA in muscle development and have
shown that RA exerts a direct effect on skeletal muscle differentiation as well as on the metabolism of murine, zebrafish and chicken skeletal muscle cells (Albagli-Curiel et al., 1993; Amengual et al., 2008; Maden et al., 2000; Reijntjes et al., 2009) . However, the effect of RA on oxidative stress and survival of skeletal muscle cells was not determined.
The cellular redox potential is maintained by a balanced regulation of prooxidative and antioxidative enzymes. Glutathione peroxidase (GPx) proteins along with superoxide (Song et al., 2010) . "Healthy" myoblasts (n = 5) were pretreated for 2 days with RA before being trypsinized, plated and immediately exposed to increasing concentrations of H 2 O 2 . Non-adherent cells were removed after 2 hours by successive washes and the percentage of adhesive cells was quantified by staining cells with Hoechst (a fluorescent DNA stain).
An increase in the H 2 O 2 concentration led to a decrease in myoblast adhesion (Fig. 3A) . 20%
of the cells were already unable to adhere to the matrix at 50 µM H 2 O 2 . At 250 µM H 2 O 2 , only 10% of total cells remained attached to the matrix (Fig. 3B) . Conversely, myoblasts that were pre-treated with RA exhibited adhesion percentages that were significantly greater than those of control (ctrl) cells at all tested doses of H 2 O 2 excepted at 250µM (Fig. 3B) . We conducted the same experiment on human myoblasts derived from patients with FSHD (n = 5; see The potential benefits of retinoid treatment of human myoblasts in transplantation assays.
Because RA can efficiently protect human myoblasts from oxidative stress-induced damage, we examined whether RA could counteract the adverse effects of cell transplantation and increased cell survival after implantation into the muscle of an adult recipient. We assessed the survival of myoblasts during the first 48 h in host skeletal muscle tissues because more than 90% of implanted myoblasts die during this period (Beauchamp et al., 1999 5A ). The level of GPx3 mRNA increased dramatically with RA or VA treatment. In contrast, catalase (cat.), glutathione synthetase (GSS), thioredoxin 1 (Thx1), thioredoxin reductase 1 (Thx-r1), superoxide dismutase 1 (SOD1), glutathione peroxidase 1 (GPx1), glutathione peroxidase 2 (GPx2), and glutathione peroxidase 4 (GPx4) levels were unchanged. We observed a modest but significant 2-fold increase in SOD2 mRNA (Fig. 5A ). Next, we performed a kinetic analysis to characterize the GPx3 mRNA profile in human myoblasts exposed to RA for up to 96 h (Fig. 5B ). This kinetic was compared to that of RAR beta mRNA, a RA target gene classified as an "immediate early gene". As expected, RA rapidly induced the expression of RAR beta mRNA with a peak of expression between 8 and 24 h. In contrast, GPx3 mRNA expression peaked between 24 and 48 h after RA treatment.
The kinetic of GPx3 expression was consistent with those observed for the anti-cytotoxic effects of RA. We did not obtain a GPx3 signal via immunocytochemistry with several sources of GPx3 antibodies (data not shown). Therefore, we measured GPx activity in human myoblasts treated with RA; as shown in Fig. 5C , RA treatment led to increased GPx activity.
We then asked whether retinoic acid signalling pathway was activated in differentiated cells.
First, we showed that GPx3 mRNA levels remained relatively stable during differentiation (Fig. 5D ). Then, myoblasts were induced to differentiate for three days and then treated two days with retinoic acid. As control, myoblasts were treated with RA at proliferative stage. As expected GPx3 and RAR beta mRNA levels were strongly induced by RA in myoblasts.
Surprisingly, RA treatment in differentiated cells slightly induced both GPx3 and RAR beta mRNA, suggesting that the retinoic acid signalling pathway is partially impaired in myotubes ( 11 whether GPx3 could be the target of others molecules with antioxidant activity ( Figure 5E ).
Myoblasts were treated for two days with RA, VA, ascorbic acid (vitamin C), Tempol (a long-lasting water soluble nitroxide), mito-Tempo (a mitochondria targeted antioxidant), NAC (N-acetyl Cysteine, a precursor in the formation of glutathione) and GPx3 mRNA levels were determined by RT-qPCR. Only RA and VA induced a significant increase of GPx3 gene expression in myoblasts (Fig. 5E ).
GPx3 is associated with the improved viability of human myoblasts.
To determine the manner in which GPx3 contributes to the antioxidant effect of RA, we knocked down GPx3 using small interference RNA (siRNA). Negative control siRNA (sictrl), which did not target any human or mouse genes, was used as a control. Cells were transfected twice (time 0 and 48 hours later) with GPx3 siRNA (siGPx3) which reduced by 98% the expression of GPx3 mRNA (Fig. 6A ). Since GPx3 is a secreted protein that scavenges radical oxygen species (ROS), we then evaluated the levels of ROS in sictrl and siGPx3 cells. Flow cytometric comparison of the ROS indicator carboxy-dichlorodihydrofluorescein diacetate (carboxy-H2DCFDA) fluorescence revealed a relative induction in ROS levels in siGPx3 compared to sictrl cells (Fig. 6B, 6D ). We detected changes in cell phenotype after transfection with siGPx3. We noticed that there were always fewer cells in siGPx3 condition with a significant number of floating cells (data not shown). Therefore, uptake of ethidium homodimer was used to assess cell viability. We observed an increase in cell death in siGPx3 myoblasts ( Fig. 6C, 6E ). RA treatment did not prevent ROS accumulation ( Fig. 6C ) and cell death in siGPx3 myoblasts (Fig. 6E ). In contrast, the antioxidant Tempol restored a level of ROS comparable to that of sictrl cells ( Based on these results, we conclude that GPx3 plays a major role in human myoblast viability and mediates the anti-cytotoxic effects of RA.
Discussion
Cell therapies for degenerative diseases of skeletal muscles have produced disappointing results but have also identified the main limitations of this approach. One of these limitations concerns the mortality of implanted skeletal muscle precursor cells (i.e., myoblasts). Several strategies can be developed to reduce cell mortality, including pharmacological approaches that utilize molecules with anti-apoptotic activities (Mias et al., 2008; Suzuki et al., 2004; Urish et al., 2009) . Recently, we showed that aldehyde dehydrogenase activity and Aldh1a1 levels were elevated in a majority of human myoblasts, and aldehyde dehydrogenase activity was associated with increased cell survival in oxidative stress conditions (Jean et al., 2011 (Yin et al., 2005) , Trx in airway epithelial cells (Chang et al., 2002) and GPx-2 in human breast cancer cells (Chu et al., 1999) . These previous results, together with our findings indicate that RA mediates its pro-survival effects by inducing several anti-apoptotic regulatory processes in a cell-specific manner.
Gpx3 is a selenoprotein and deficiency in selenium has been shown to affect skeletal muscle. Selenium is an essential trace element, known to be essential and potentially toxic for Castets et al., 2012) . According to our data, since GPx3 could protect adult muscle precursor cells from oxidative damages, it is therefore interesting to evaluate the regenerative capacity of GPx3 -/-mice and whether selenium deficiency is associated with impaired muscle repair and regeneration in human.
Our study shows that GPx3 is a target gene of RA and plays a role in both the anti- targets. We hypothesized that adhesion molecules would be one of those targets. We started to explore this hypothesis using transcriptomic and proteomic approaches.
Myoblast transplantation is a potential treatment for degenerative muscle disease or myopathy, but unfortunately, the first clinical trials were disappointing (Skuk and Tremblay, 2011) . Several studies have shown that there is a time period of three days after transplantation that will have a major impact on the ability of grafted cells to regenerate muscle tissue. Riederer et al reported that implanted myoblasts started to differentiate by day 3 after transplantation, limiting their ability to proliferate and to expand into the host tissue. 17 efficacy of future clinical trials. In conclusion, the results of our study support the hypothesis that GPx3 and RA play an important function in muscle stem cells survival, a critical role that could ensure efficient adult skeletal muscle regeneration. 
Material and Methods

Chemicals and reagents
All
Cell adhesion assay
Myoblasts were either left untreated or pre-treated twice with 10 -7 M RA for 48 hours (each 24 hours). Myoblasts were subsequently trypsinized, seeded on collagen-coated dishes and stimulated with various concentrations of H O . After 2 hours, non-adherent cells were first removed by washing with culture medium. Next, to assess the cell adhesion, the adherent cells were stained with Hoechst, a DNA intercalating dye that stains nuclei, and fixed with 4% paraformaldehyde. Five separate fields were photographed using a fluorescence microscope (ZEISS Imager M1 AX10). Cell counting was performed using Histolab software. Charbonnières, France). The luciferase activity (i.e., reporter activity) was measured and normalized to the pRL-tk activity.
Journal of Cell Science Accepted manuscript
Microarray analysis
Total RNA was prepared from one culture of human healthy myoblasts treated (or not) with RA for three days (N042; see Table 2 and Table s1 in supplementary material) using a NucleoSpin RNA II system (Macherey-Nagel, Hoerdt, France). A double amplification of total RNA was used to generate a suitable quantity of labeled cRNA for hybridization to GeneChip® Human Genome U133 Plus 2.0 arrays according to the manufacturer's protocol. 
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RT-qPCR
Total RNA was prepared from cultured cells using a NucleoSpin RNA II system (MachereyNagel, Hoerdt, France), and cDNA was prepared using a Verso cDNA kit (Thermo Scientific, Ilkirch, France).
The expression of various genes was analyzed via reverse transcription polymerase chain reaction (RT-qPCR) with a LightCycler (Roche Diagnostics, Meylan, France) and the following procedure: 95° C for 10 sec, 60° C for 10 sec and 72° C for 15 sec. Primers were designed using Light Cycler software design2 probe5 (Roche Diagnostics, Meylan, France) and were tested for homology with other sequences in the NCBI BLAST database. We performed relative quantification. The calculation method used was the standard curve method (for each experimental sample, the amount of target and endogenous reference RPP0
is determined from the appropriate standard curve (target and RPP0 respectively)). Then, the target amount is divided by the RPP0 amount to obtain a normalized target value. One of the normalised target values in experimental control conditions (expressed in proliferative cells or control non-treated cells for example) is set up at one. Each of the target values is expressed as n-fold differences relative to the experimental control. Western blot were normalised against αTubulin expression.
Cell transplantation
All surgical procedures were performed on animals and were approved by the Institutional 
Statistical analysis
The statistical significance of the differences was determined using Mann-Whitney tests. * and NAC (5 X 10 -3 M). Total RNA was isolated and subjected to RT-qPCR analysis of the relative expression levels of GPx3. Table 1 Journal of Cell Science Accepted manuscript 
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